Inventor · disambiguated record
Andrew Mark Lew
Also filed as: LEW ANDREW · LEW ANDREW M · LEW ANDREW MARK
8 granted patents·4 pending applications·31 citations·filing 1996–2020
83Inventor score
Top patents by PatentIndex Score
12 records- 0183US9988431B2Dendritic cell marker and uses thereofWALTER AND ELIZA HALL INSTITUTE OF MEDICAL RES·Filed 2013·Granted Jun 5, 2018·10 cites·7 claims
- 0280US8349575B2Relay vaccineQUEENSLAND INST MED RES·Filed 2011·Granted Jan 8, 2013·7 cites·3 claims
- 0377US8426565B2Dendritic cell marker and uses thereofLAHOUD MIREILLE HANNA·Filed 2008·Granted Apr 23, 2013·9 cites·69 claims
- 0466US2010087436A1Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejectionABBOTT LAB·Filed 2009·Application pending·0 cites
- 0562US7423023B2Enhancement of immune response using targeting moleculesCSL LTD·Filed 2002·Granted Sep 9, 2008·1 cites·7 claims
- 0651US7455984B2Immunoreactive and immunotherapeutic moleculesINST MEDICAL W & E HALL·Filed 2002·Granted Nov 25, 2008·0 cites·3 claims
- 0749US7423016B2Immune response targeting moleculesCSL LTD·Filed 2002·Granted Sep 9, 2008·0 cites·4 claims
- 0848US2016175316A1Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejectionABBVIE INC·Filed 2015·Application pending·0 cites
- 0947US2006121031A1Relay vaccineMCKENZIE BRENT S·Filed 2004·Application pending·0 cites
- 1043US2020298194A1Aramid amphiphile self-assembled nanostructuresMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Application pending·0 cites
- 1137US8097430B2Antigen targetingMCKENZIE BRENT·Filed 2002·Granted Jan 17, 2012·0 cites·11 claims
- 1230US6818217B1Immunoreactive peptidesAMRAD CORP LTD·Filed 1996·Granted Nov 16, 2004·4 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Andrew Mark Lew files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →